Skip to content

A Study of the Relationship of Gut Microbial Composition and Stroke Outcome

A Study of the Relationship of Gut Microbial Composition and Stroke Outcome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03470506
Acronym
GEMSTONE
Enrollment
300
Registered
2018-03-20
Start date
2018-02-20
Completion date
2022-07-01
Last updated
2019-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Brief summary

The purpose of this study is to investigate the relationship between gut microbiome (bacteria in the gut), inflammation and the injured brain. It has been established that bacteria in the gut play key roles in digestion, nutrition absorption and immune response of the entire body. Human intestinal bacteria composition in the gut has been associated with several stroke risk factors including obesity, insulin resistance, diabetes and hypertension. If we can establish a relationship between gastrointestinal microbial community composition and ischemic stroke outcomes could lead to dietary interventions in the future to improve recovery after a stroke.

Interventions

OTHERStool Samples

Stool samples will be collected at baseline and 3 months to assess differences in microbiome composition between groups

Sponsors

University of Colorado, Denver
CollaboratorOTHER
University of Virginia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Men and women at least 18 years of age. 2. Willing and able to attend all study visits. 3. English speaking. 4. Must have had a stroke that occurred within 48 hours of admission to the Stroke Unit as determined by a neurologist.

Exclusion criteria

1. History of inflammatory bowel disease. 2. Receiving antibiotics within 30 days of entry into the study. 3. History of institutionalization for mental illness within the last year. 4. Unable to consent and does not have a surrogate available to consent on their behalf.

Design outcomes

Primary

MeasureTime frameDescription
Measured differences in taxonomic make-up and the relative frequency of the gut microbial composition in relation to excellent vs. poor stroke outcomeBaseline, 3 monthsThe primary outcome in this case-comparison design of those with excellent vs. non-excellent ischemic stroke outcomes at 3 months as measured by the National Institutes of Health Stroke Scale (NIHSS) is the taxonomic make up of the gut microbial composition. In other words, comprehensive microbiota survey results from 16S rRNA gene sequencing from individuals with excellent outcomes versus all other outcomes at 3 months are the outcome.

Secondary

MeasureTime frameDescription
Cogstate cognitive correlates and post-stroke microbial compositionBaseline, 3 monthsDescriptive analyses will be used to develop a preliminary understanding of microbiome composition in relation to measures of cognitive functioning as derived from Cogstate cognitive assessment results at baseline and 3 months post- ischemic stroke

Countries

United States

Contacts

Primary ContactSonya A Gunter, MS
sag7bf@hscmail.mcc.virginia.edu434-924-9664

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026